Bp Plc trimmed its position in Stryker Co. (NYSE:SYK) by 14.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 37,000 shares of the medical technology company’s stock after selling 6,000 shares during the period. Bp Plc’s holdings in Stryker were worth $5,800,000 as of its most recent SEC filing.
Other large investors have also recently bought and sold shares of the company. Northwest Wealth Management LLC grew its position in Stryker by 103.6% in the 4th quarter. Northwest Wealth Management LLC now owns 169 shares of the medical technology company’s stock valued at $26,000 after buying an additional 86 shares during the last quarter. Horan Securities Inc. purchased a new position in Stryker in the 4th quarter valued at $30,000. Moody National Bank Trust Division purchased a new position in Stryker in the 4th quarter valued at $32,000. Westside Investment Management Inc. grew its position in Stryker by 38.7% in the 4th quarter. Westside Investment Management Inc. now owns 233 shares of the medical technology company’s stock valued at $37,000 after buying an additional 65 shares during the last quarter. Finally, Exane Derivatives purchased a new position in Stryker in the 4th quarter valued at $39,000. Hedge funds and other institutional investors own 74.99% of the company’s stock.
In related news, VP M Kathryn Fink sold 180 shares of the business’s stock in a transaction dated Monday, February 4th. The shares were sold at an average price of $176.77, for a total value of $31,818.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Timothy J. Scannell sold 9,332 shares of the business’s stock in a transaction dated Tuesday, December 18th. The shares were sold at an average price of $161.60, for a total transaction of $1,508,051.20. The disclosure for this sale can be found here. Insiders sold a total of 43,259 shares of company stock valued at $7,515,747 in the last three months. 7.30% of the stock is currently owned by corporate insiders.
A number of research firms recently weighed in on SYK. Zacks Investment Research upgraded shares of Stryker from a “hold” rating to a “buy” rating and set a $199.00 price objective on the stock in a research report on Monday, February 4th. Oppenheimer set a $170.00 price objective on shares of Stryker and gave the company a “hold” rating in a research report on Friday, November 9th. Cantor Fitzgerald restated a “neutral” rating on shares of Stryker in a research report on Friday, January 18th. Finally, Canaccord Genuity boosted their target price on shares of Stryker from $185.00 to $190.00 and gave the stock a “buy” rating in a research report on Wednesday, January 30th. Seven investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $185.37.
Shares of NYSE SYK opened at $185.29 on Thursday. The firm has a market cap of $68.34 billion, a price-to-earnings ratio of 25.35, a P/E/G ratio of 2.25 and a beta of 0.86. Stryker Co. has a one year low of $144.75 and a one year high of $186.17. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.41 and a current ratio of 2.02.
Stryker (NYSE:SYK) last released its quarterly earnings results on Tuesday, January 29th. The medical technology company reported $2.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.15 by $0.03. The business had revenue of $3.80 billion during the quarter, compared to the consensus estimate of $3.73 billion. Stryker had a return on equity of 27.60% and a net margin of 26.12%. Analysts forecast that Stryker Co. will post 8.12 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, April 30th. Investors of record on Friday, March 29th will be paid a $0.52 dividend. This represents a $2.08 annualized dividend and a yield of 1.12%. The ex-dividend date of this dividend is Thursday, March 28th. Stryker’s payout ratio is 28.45%.
ILLEGAL ACTIVITY NOTICE: This report was first posted by American Banking News and is the property of of American Banking News. If you are accessing this report on another publication, it was stolen and reposted in violation of U.S. & international copyright laws. The correct version of this report can be read at https://www.americanbankingnews.com/2019/02/14/bp-plc-has-5-80-million-position-in-stryker-co-syk.html.
Stryker Company Profile
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.
Recommended Story: How a Put Option Works
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.